|
Market Closed -
NYSE
00:00:03 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.870 USD | -4.10% |
|
-9.66% | -44.01% |
| 09-09 | TPG explores $5 billion sale of healthcare software company Lyric, sources say | RE |
| 08-11 | Clarivate Insider Bought Shares Worth $1,671,500, According to a Recent SEC Filing | MT |
Company Valuation: Clarivate Plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,151 | 5,623 | 6,148 | 3,609 | 2,209 | 1,196 | - | - |
| Change | - | -65.18% | 9.33% | -41.3% | -38.78% | -45.85% | - | - |
| Enterprise Value (EV) | 21,207 | 10,280 | 10,498 | 7,832 | 6,201 | 1,196 | 1,196 | 1,196 |
| Change | - | -51.52% | 2.12% | -25.39% | -20.82% | -80.71% | 0% | 0% |
| P/E | -48x | -1.4x | -6.3x | -5.29x | -11.1x | -3.53x | -46.8x | 93.5x |
| PBR | 1.35x | 0.89x | 1.03x | 0.68x | 0.44x | - | - | - |
| PEG | - | -0x | 0.1x | 0.2x | 0.2x | -0x | 0.5x | -1x |
| Capitalization / Revenue | 8.61x | 2.11x | 2.34x | 1.41x | 0.9x | 0.55x | 0.59x | 0.57x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.55x | 0.59x | 0.57x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.27x | 1.32x | 1.27x |
| EV / EBIT | 0x | 0x | 0x | -0x | 0x | -12.5x | 7.9x | 7.12x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.49 | -5.97 | -1.47 | -0.96 | -0.3 | -0.53 | -0.04 | 0.02 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,877 | 2,661 | 2,629 | 2,557 | 2,455 | 2,170 | 2,028 | 2,093 |
| EBITDA 1 | 800.4 | 1,113 | 1,117 | 1,060 | 1,002 | 939.6 | 906.2 | 942.1 |
| EBIT 1 | 262.6 | 402.2 | 408.9 | -275.6 | 71.5 | -95.9 | 151.4 | 168 |
| Net income 1 | -312 | -4,036 | -986.6 | -668 | -201.1 | -342.1 | -24.2 | 13.1 |
| Net Debt | 5,056 | 4,657 | 4,350 | 4,224 | 3,992 | - | - | - |
| Reference price 2 | 23.520 | 8.340 | 9.260 | 5.080 | 3.340 | 1.870 | 1.870 | 1.870 |
| Nbr of stocks (in thousands) | 686,687 | 674,255 | 663,923 | 710,404 | 661,435 | 639,664 | - | - |
| Announcement Date | 10/03/22 | 01/03/23 | 27/02/24 | 19/02/25 | 24/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.53x | - | - | -.--% | 1.2B | |
| 25.6x | 9.21x | 17.44x | 0.96% | 121B | |
| 24.01x | 5.46x | 13.7x | 2.64% | 42.14B | |
| 27.78x | 13.13x | 21.29x | 1.48% | 40.32B | |
| 25.29x | 3.68x | 11.62x | 1.33% | 19.85B | |
| 12.64x | 2.97x | 8.89x | 4.07% | 17.14B | |
| 20.74x | 4.87x | 12.18x | 3.2% | 16.4B | |
| 18.22x | 3.72x | 10.55x | 0.66% | 14.89B | |
| 17.23x | 4.19x | 11.22x | 1.73% | 9.24B | |
| 53.89x | - | - | 0.58% | 4.23B | |
| Average | 22.19x | 5.90x | 13.36x | 1.66% | 28.65B | |
| Weighted average by Cap. | 24.24x | 7.73x | 15.62x | 1.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CLVT Stock
- Valuation Clarivate Plc
Select your edition
All financial news and data tailored to specific country editions
